What are the normal reference ranges for creatine kinase (CK) in children across different age groups?

Normal Reference Ranges for Creatine Kinase (CK) in Children

The normal reference range for creatine kinase in children varies significantly by age, with the highest values occurring in the first year of life (peaking around age 1 at approximately 2.7-2.9 µkat/L or 160-170 U/L at the 50th percentile), followed by a gradual decline, and then a marked sex-based divergence during adolescence where boys can have upper limits up to 14.48 µkat/L (850 U/L) compared to 5.74 µkat/L (~340 U/L) in girls by age 18.

Age-Specific Reference Ranges

Neonatal Period (Birth to 1 Month)

The neonatal period shows the most dramatic changes in CK values:

• Days 1-3: Upper limit ≤370 U/L 1
• Days 4-10: Upper limit ≤200 U/L 1
• Days 11-31: Upper limit ≤100 U/L 1

Important caveat: CK is highest in the second 12-hour period of life (median ~318 ng/mL), with only 57.6% of newborns testing below 360 ng/mL during this time 2. By 72 hours of age, median CK drops to 97 ng/mL, and 96% of infants have concentrations below 360 ng/mL 2. This dramatic early decline must be considered when interpreting neonatal CK values, particularly for newborn screening programs.

Infancy and Early Childhood (2 Months to 1 Year)

CK levels rise during the first year of life, peaking shortly after age one 3:

• Peak at ~1 year:
  • Girls: P50 = 2.7 µkat/L (approximately 160 U/L)
  • Boys: P50 = 2.9 µkat/L (approximately 170 U/L)

Children (2 Months to 15 Years, Pre-Puberty)

For children aged 2 months to 15 years without sex differentiation:

• Upper limit: ≤90 U/L 1

This represents the most stable period for CK values before pubertal changes occur.

Sex-Specific Ranges During Adolescence

The most critical distinction occurs during and after puberty, where sex-based differences become pronounced 3:

Adolescent and Young Adult Females (≥13 years)

• 97.5th percentile (upper reference limit):
  • General population: 170 U/L (White ethnicity)
  • Range across studies: 135-248 U/L

Adolescent and Young Adult Males (≥13 years)

• 97.5th percentile (upper reference limit):
  • At age 18: 14.48 µkat/L (~850 U/L) 3
  • General population: 314 U/L (White ethnicity)
  • Range across studies: 227-440 U/L

Boys have significantly higher mean CK levels during adolescence (regression coefficient = 0.29, p < 0.001) 3, reflecting increased muscle mass development.

Critical Clinical Considerations

Factors That Lower CK Values

The following factors show significant inverse correlation with CK levels 3:

• Oral contraceptive use in adolescent females
• Extreme underweight
• Underweight status
• Obesity

Monitoring Thresholds in Clinical Practice

When monitoring children on medications that can cause muscle toxicity (such as statins for familial hypercholesterolemia):

• Threshold for concern: CK >10 times the upper limit of normal 4
• Consider impact of physical activity when interpreting elevated values 4

Laboratory Method Considerations

Critical point: Different assay methodologies require method-specific reference ranges 5. The lack of specificity of Jaffe-based methods is particularly problematic at the low creatinine values (not CK, but relevant for concurrent kidney function assessment) encountered in children 5. Many laboratories appropriately use enzymatic assays for pediatric populations 6.

Practical Algorithm for Interpretation

1. Identify the child's age category:

   • Neonatal (0-31 days): Use day-specific ranges
   • Infant/young child (2 months-12 years): Use ≤90 U/L
   • Adolescent (≥13 years): Use sex-specific ranges

2. For adolescents, apply sex-specific upper limits:

   • Females: ~170-248 U/L
   • Males: ~314-440 U/L (can be higher up to ~850 U/L by age 18)

3. Consider modifying factors:

   • Recent physical activity
   • Oral contraceptive use (females)
   • Body weight status
   • Ethnicity (if applicable)

4. Clinical action thresholds:

   • Values within age/sex-specific range: Normal
   • Values 1-10× upper limit: Consider repeat testing, assess for recent activity, medication effects
   • Values >10× upper limit: Urgent evaluation for muscle disease or injury 4

The key pitfall to avoid is applying adult reference ranges to children or failing to account for the dramatic physiological changes during the first year of life and during puberty, which will lead to either over-diagnosis of muscle disease or missed pathology.